Medical and Pharmaceutical Natera and RenaCARE aim for early detection of kidney disease Natera (NASDAQ:NTRA) acquired full enrolment for the RenaCARE (Renasight Clinical Application, Review and Evaluation) study, which is a prospective, multi-center clinical trial to determine... Joseph MortonAugust 11, 2022
Medical and Pharmaceutical The Mugglehead technology roundup: alternative medicine options edition There are a handful of truisms in terms of alternative medicine. The future of healthcare is often found in the past, and the future... Joseph MortonJuly 18, 2022